Purchase Order 75N95022P00011
- Not listed
- The National Institute of Neurological Disorders and Stroke awarded a purchase order to Toxstrategies, LLC on September 20, 2022, for toxicology consulting services supporting the NIH Blueprint Neurotherapeutics Network, Helping to End Addiction Long-term Initiative, and other NIH neuroscience-focused drug discovery and development programs, with a ceiling value of $2,347,472.64. Work is performed in Austin, Texas. The order procures senior-level toxicology consulting for drug discovery and...
- This federal contract award provides small molecules and biologics toxicology consultant support services to the National Institute on Drug Abuse (NIDA), a civilian agency. The $28,000.00 purchase order contract was awarded to Toxstrategies, LLC, a for-profit small business, on September 22, 2025 with a completion date of September 21, 2028. The work is to be performed in Katy, Texas. The original solicitation was a pre-solicitation notice from the National Institute of Neurological Disorders...
- The National Institute on Drug Abuse issued a purchase order to Certara USA Inc. for toxicology consulting services supporting NIH neuroscience-focused drug discovery and development programs, with a ceiling value of $2,145,075 and an award date of September 20, 2022. Work is performed in Princeton, New Jersey. The order provides toxicology consulting services to the National Institute of Neurological Disorders and Stroke, the NIH Blueprint Neurotherapeutics Network, the Helping to End Addiction...
- This is a $444,500.00 labor-hour federal contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to In Vitro Strategies Limited Liability Company, a woman-owned small business. The contract is for the provision of senior-level consultant support services for bioactivity assay development to support the NINDS Blueprint Neurotherapeutics Program and other NIH neuroscience-focused drug development...
- The National Institute on Drug Abuse awarded a $67,270 purchase order to Certara USA Inc. on September 22, 2025, for small molecules and biologics toxicology consultant support services. The contract, which will be performed in Wayne, Pennsylvania, extends through September 21, 2028, and utilizes a labor hours pricing model with no set-aside designation. Certara USA Inc. is a leading drug development and drug safety consultancy specializing in biosimulation software and expert consulting...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services, awarded a $9,000.00 Purchase Order contract for Medicinal Chemistry Consulting Services to Nigel J Liverton, a small business located in San Antonio, Texas. The contract, which runs through September 28, 2026, is to provide technical guidance and recommendations to support the NIH Blueprint Neurotherapeutics Network drug discovery and development programs, as well as other NIH...
- The National Institute of Neurological Disorders and Stroke issued a $3.39 million delivery order to IIT Research Institute on June 25, 2026, for SSL GLP and non-GLP toxicology studies. The order is issued under the Pharmacology and Toxicology for Therapeutics Program, a $174.47 million IDIQ with the National Institute of Neurological Disorders and Stroke. Place of performance is Chicago, IL. The order extends through December 25, 2027, and is priced on a cost-plus-fixed-fee basis with no...
- The National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, awarded a $20,000.00 firm fixed price purchase order contract to Leadingedge Pharmtox, LLC, a self-certified small disadvantaged business, for toxicology consulting services related to reproductive science and health. The contract, which was set aside for small businesses, has an ultimate completion date of August 24, 2025. Leadingedge Pharmtox, LLC...
- The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $16,000 purchase order to Cellx, Inc., a small business, on September 29, 2025, for pharmaceutics formulation, chemistry manufacturing and controls (CMC) consulting services supporting drug discovery and development programs. The contract, which runs through September 28, 2028, provides specialized subject matter expert consultation for small molecules and biologics development, with...
- This $509,100 federal contract was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Steven Young Consulting LLC to provide Medicinal Chemistry consultant support services. The contract supports the NIH Blueprint Neurotherapeutics Network drug discovery programs, the Help End Addiction Long-Term (HEAL) initiative to develop non-addictive pain therapies, and other NIH neuroscience drug development efforts....
The National Institutes of Health, National Institute of Neurological Disorders and Stroke awarded a $591,600 labor-hour contract to Toxstrategies, LLC to provide toxicology consulting services in support of the Helping to End Addiction Long-term Initiative and other neuroscience drug discovery programs. The contract is set aside for small businesses. Toxstrategies will provide a minimum of 20 hours annually of consulting services on Lead Development Teams, including evaluating chemical structures and testing strategies, advising on toxicology optimization, and accompanying NIH staff on site visits. The contract has a one-year base period and two one-year option periods, with work performed primarily at the contractor's site and through electronic communication.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Toxicology Consulting Services | NIH-NINDS-CSS-21-005337 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/1 | 7/21/21, 3:48 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Vendor DUNS or Name Change - Non-Novation | $0 | 2/9/24 | |
| P00002 | Other Administrative Action | $0 | 9/23/22 | |
| P00001 | Exercise an Option | $14.7k | 8/3/22 | |
| Not listed | Not listed | $24.5k | 11/3/21 |